Just over one year ago I covered the California-based Pharma Amgen Inc.'s (AMGN) Q4 and full-year 2024 earnings in a note for Seeking Alpha, assigning stock a Hold rating. Shares have risen in value ...
Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results